122307-33-9 Usage
Uses
Used in Pharmaceutical Industry:
2-PyridineMethanol, 5-broMo-4-Methoxyis used as an intermediate in the synthesis of various pharmaceuticals. Its unique chemical structure allows it to be a key component in the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, 2-PyridineMethanol, 5-broMo-4-Methoxyserves as an intermediate in the production of agrochemicals, such as pesticides and herbicides. Its incorporation into these products can enhance their effectiveness in controlling pests and weeds.
Used in Chemical Research and Development:
2-PyridineMethanol, 5-broMo-4-Methoxyis utilized in various organic transformations in chemical research and development. Its unique properties make it a valuable compound for exploring new chemical reactions and synthesizing novel compounds with potential applications in various fields.
Used in Antifungal and Antimicrobial Applications:
Due to its biological activities, 2-PyridineMethanol, 5-broMo-4-Methoxyhas been studied for its potential use as an antifungal and antimicrobial agent. Its ability to inhibit the growth of fungi and bacteria makes it a promising candidate for use in medical and industrial settings to combat infections and contamination.
Check Digit Verification of cas no
The CAS Registry Mumber 122307-33-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,2,3,0 and 7 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 122307-33:
(8*1)+(7*2)+(6*2)+(5*3)+(4*0)+(3*7)+(2*3)+(1*3)=79
79 % 10 = 9
So 122307-33-9 is a valid CAS Registry Number.
122307-33-9Relevant academic research and scientific papers
2--1H-thienoimidazoles. A Novel Class of Gastric H+/K+-ATPase Inhibitors
Weidmann, Klaus,Herling, Andreas W.,Lang, Hans-Jochen,Scheunemann, Karl-Heinz,Rippel, Robert,et al.
, p. 438 - 450 (2007/10/02)
2-thienoimidazoles were synthesized and investigated as potential inhibitors of gastric H+/K+-ATPase.The isomers of the two possible thienoimidazole series were found to be potent inhibitors of gastric acid secretion in vitro and in vivo.Structure-activity relationships indicate that especially lipophilic alkoxy, benzyloxy, and phenoxy substituents with additional electron-demanding properties in the 4-position of the pyridine moiety combined with an unsubstituted thienoimidazole lead to highly active compounds with a favorable chemical stability.Various substitution patterns in the thienoimidazole moiety result in lower biological activity.The heptafluorobutyloxy derivative saviprazole (HOE 731, 5d) was selected for further development and is currently undergoing clinical evaluation.Comprehensive pharmacological studies indicate a pharmacodynamic profile different to omeprazole, the first H+/K+-ATPase blocker introduced on the market.
